
BPaLM Regimen: A Lifesaving Breakthrough or Just Another Medical Mirage Awaiting Political Will?
New Delhi: The BPaLM regimen (Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin) is being hailed as a breakthrough in the fight against multidrug-resistant tuberculosis (MDR-TB). But is it the ultimate answer to a disease that has plagued humanity for …